1. Home
  2. DUOT vs QNCX Comparison

DUOT vs QNCX Comparison

Compare DUOT & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duos Technologies Group Inc.

DUOT

Duos Technologies Group Inc.

HOLD

Current Price

$7.51

Market Cap

158.9M

Sector

Technology

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$0.10

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DUOT
QNCX
Founded
1990
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
158.9M
167.0M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
DUOT
QNCX
Price
$7.51
$0.10
Analyst Decision
Strong Buy
Hold
Analyst Count
1
3
Target Price
$14.00
$10.00
AVG Volume (30 Days)
662.6K
16.2M
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
10.90
N/A
EPS
N/A
N/A
Revenue
$7,280,885.00
N/A
Revenue This Year
$286.66
N/A
Revenue Next Year
$44.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.84
$0.08
52 Week High
$12.17
$4.55

Technical Indicators

Market Signals
Indicator
DUOT
QNCX
Relative Strength Index (RSI) 42.47 29.94
Support Level $6.99 $0.09
Resistance Level $8.45 $0.98
Average True Range (ATR) 0.39 0.01
MACD 0.06 0.06
Stochastic Oscillator 32.72 66.12

Price Performance

Historical Comparison
DUOT
QNCX

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: